201 related articles for article (PubMed ID: 7774621)
1. Biphasic effect of interferon-gamma in murine collagen-induced arthritis.
Boissier MC; Chiocchia G; Bessis N; Hajnal J; Garotta G; Nicoletti F; Fournier C
Eur J Immunol; 1995 May; 25(5):1184-90. PubMed ID: 7774621
[TBL] [Abstract][Full Text] [Related]
2. Suppression of murine collagen-induced arthritis with monoclonal anti-Ia antibodies and augmentation with IFN-gamma.
Cooper SM; Sriram S; Ranges GE
J Immunol; 1988 Sep; 141(6):1958-62. PubMed ID: 3139747
[TBL] [Abstract][Full Text] [Related]
3. The effects of NO synthase inhibitors on murine collagen-induced arthritis do not support a role of NO in the protective effect of IFN-gamma.
Vermeire K; Thielemans L; Matthys P; Billiau A
J Leukoc Biol; 2000 Jul; 68(1):119-24. PubMed ID: 10914498
[TBL] [Abstract][Full Text] [Related]
4. Therapy against murine collagen-induced arthritis with T cell receptor V beta-specific antibodies.
Chiocchia G; Boissier MC; Fournier C
Eur J Immunol; 1991 Dec; 21(12):2899-905. PubMed ID: 1836185
[TBL] [Abstract][Full Text] [Related]
5. High susceptibility to collagen-induced arthritis in mice lacking IFN-gamma receptors.
Manoury-Schwartz B; Chiocchia G; Bessis N; Abehsira-Amar O; Batteux F; Muller S; Huang S; Boissier MC; Fournier C
J Immunol; 1997 Jun; 158(11):5501-6. PubMed ID: 9164973
[TBL] [Abstract][Full Text] [Related]
6. Down-regulation of Th1-mediated pathology in experimental arthritis by stimulation of the Th2 arm of the immune response.
Mauri C; Feldmann M; Williams RO
Arthritis Rheum; 2003 Mar; 48(3):839-45. PubMed ID: 12632440
[TBL] [Abstract][Full Text] [Related]
7. Potent adjuvant effect by anti-CD40 in collagen-induced arthritis. Enhanced disease is accompanied by increased production of collagen type-II reactive IgG2a and IFN-gamma.
Tellander AC; Michaëlsson E; Brunmark C; Andersson M
J Autoimmun; 2000 Jun; 14(4):295-302. PubMed ID: 10882055
[TBL] [Abstract][Full Text] [Related]
8. Differential activities of immunogenic collagen type II peptides in the induction of nasal tolerance to collagen-induced arthritis.
Chu CQ; Londei M
J Autoimmun; 1999 Feb; 12(1):35-42. PubMed ID: 10028020
[TBL] [Abstract][Full Text] [Related]
9. Blockage of interleukin-6 receptor ameliorates joint disease in murine collagen-induced arthritis.
Takagi N; Mihara M; Moriya Y; Nishimoto N; Yoshizaki K; Kishimoto T; Takeda Y; Ohsugi Y
Arthritis Rheum; 1998 Dec; 41(12):2117-21. PubMed ID: 9870868
[TBL] [Abstract][Full Text] [Related]
10. Suppression of collagen-induced arthritis by oral or nasal administration of type II collagen.
Garcia G; Komagata Y; Slavin AJ; Maron R; Weiner HL
J Autoimmun; 1999 Nov; 13(3):315-24. PubMed ID: 10550219
[TBL] [Abstract][Full Text] [Related]
11. Induction of Th2 cytokines and control of collagen-induced arthritis by nondepleting anti-CD4 Abs.
Chu CQ; Londei M
J Immunol; 1996 Sep; 157(6):2685-9. PubMed ID: 8805674
[TBL] [Abstract][Full Text] [Related]
12. (5R)-5-hydroxytriptolide attenuated collagen-induced arthritis in DBA/1 mice via suppressing interferon-gamma production and its related signaling.
Zhou R; Tang W; Ren YX; He PL; Zhang F; Shi LP; Fu YF; Li YC; Ono S; Fujiwara H; Yang YF; Zuo JP
J Pharmacol Exp Ther; 2006 Jul; 318(1):35-44. PubMed ID: 16574782
[TBL] [Abstract][Full Text] [Related]
13. Effect of a monoclonal antibody against interleukin-4 on collagen-induced arthritis in mice.
Yoshino S
Br J Pharmacol; 1998 Jan; 123(2):237-42. PubMed ID: 9489611
[TBL] [Abstract][Full Text] [Related]
14. Comparison of nasal and oral tolerance for the prevention of collagen induced murine arthritis.
Higuchi K; Kweon MN; Fujihashi K; McGhee JR; Kiyono H
J Rheumatol; 2000 Apr; 27(4):1038-44. PubMed ID: 10782834
[TBL] [Abstract][Full Text] [Related]
15. Contribution of OX40/OX40 ligand interaction to the pathogenesis of rheumatoid arthritis.
Yoshioka T; Nakajima A; Akiba H; Ishiwata T; Asano G; Yoshino S; Yagita H; Okumura K
Eur J Immunol; 2000 Oct; 30(10):2815-23. PubMed ID: 11069062
[TBL] [Abstract][Full Text] [Related]
16. Conversion in vivo from an early dominant Th0/Th1 response to a Th2 phenotype during the development of collagen-induced arthritis.
Doncarli A; Stasiuk LM; Fournier C; Abehsira-Amar O
Eur J Immunol; 1997 Jun; 27(6):1451-8. PubMed ID: 9209498
[TBL] [Abstract][Full Text] [Related]
17. Treatment with an anti-IL-4 monoclonal antibody blocks suppression of collagen-induced arthritis in mice by oral administration of type II collagen.
Yoshino S
J Immunol; 1998 Mar; 160(6):3067-71. PubMed ID: 9510213
[TBL] [Abstract][Full Text] [Related]
18. Reduced susceptibility to collagen-induced arthritis in mice deficient in IFN-gamma receptor.
Kageyama Y; Koide Y; Yoshida A; Uchijima M; Arai T; Miyamoto S; Ozeki T; Hiyoshi M; Kushida K; Inoue T
J Immunol; 1998 Aug; 161(3):1542-8. PubMed ID: 9686622
[TBL] [Abstract][Full Text] [Related]
19. High doses of interleukin-12 inhibit the development of joint disease in DBA/1 mice immunized with type II collagen in complete Freund's adjuvant.
Hess H; Gately MK; Rüde E; Schmitt E; Szeliga J; Germann T
Eur J Immunol; 1996 Jan; 26(1):187-91. PubMed ID: 8566065
[TBL] [Abstract][Full Text] [Related]
20. Interferon-gamma regulates susceptibility to collagen-induced arthritis through suppression of interleukin-17.
Chu CQ; Swart D; Alcorn D; Tocker J; Elkon KB
Arthritis Rheum; 2007 Apr; 56(4):1145-51. PubMed ID: 17393396
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
